Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

PHASE1UnknownINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2020

Conditions
Advanced Gastric Cancer
Interventions
DRUG

CM082 plus paclitaxel

"CM082 treatment: A treatment cycle is defined as 28 days. Oral CM082 tablets was given once daily for 3 weeks followed by 1-week break with escalating dose (100 mg, 150 mg and 200mg).~Drug: Paclitaxel Paclitaxel 80 mg/m2 will be administrated by intravenous injection on days 1, 8, 15 of a 28-day cycle for no more than 6 cycles."

Trial Locations (1)

100021

RECRUITING

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AnewPharma

INDUSTRY

NCT03286244 - Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter